M
MedGenome Labs
A genomics-driven research and diagnostics company with a mission to improve global health by decoding the genetic information contained in an individual’s genome
At a glance
- Founded
- 2013
- Headquarters
- Foster City, United States
- Sector
- Biotech & Life Sciences
- Power Law
- Colt$25–100M revenue
Latest news
Press, funding announcements and product moves mentioning MedGenome Labs.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A5 investors entered at this stage
- PCPapillon Capital
- VIVidinovo
- EVEmerge Ventures
- SISingapore
- ICInnoVen Capital
Series B and later9 investors entered at this stage
- HLHDFC ERGO General Insurance Company Limited
Sofina- NHNovo Holdings
Sequoia- LILeapFrog Investments
- NSNovo Seeds
- MIMaj Invest
- ZCZodius Capital
International Finance Corporation
Source: Dealroom Talent Intelligence.
Global footprint
across markets
Investments and acquisitions
Disclosed deals where MedGenome Labs was the backer or acquirer, 2016–2026. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
5 deals across MedGenome Labs's capital deployment.
Where the deals concentrate by sector, stage, and decade.
MedGenome Labs's portfolio, mapped.
Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.
Market sentiment
An AI-synthesised read of the highest-engagement posts about MedGenome Labs on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See MedGenome Labs on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.